India's Pharma Market Hit By Slowdown In Growth Of Anti-Infective Sales
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry, including domestic drug makers such as Cipla and foreign ones such as Pfizer, has been seeing poor growth in the anti-infective drug sector in recent months.